AI Adoption and Assurance

Version: 1.1.0 Last updated: 2026-07-16 Status: Informative OAIES implementation profile

Purpose

Scale AI use through measured enablement and risk-based assurance rather than seat counts.

Why

Usage can grow while quality, security, and outcomes degrade.

When

Use for quarterly operating reviews.

How

1. Measure outcome lead time, accepted-change rate, escaped defects, evaluation coverage, severe incidents, override rate, unit cost, and skill attainment.
2. Baseline before interventions and use matched comparisons where possible.
3. Review by use case and risk, not individual surveillance.
4. Fund remediation for recurring control failures.
5. Stop or retire use cases that cannot meet minimum controls.

Measurement model

Define the unit of analysis before collecting data: use case, team workflow, release, or user outcome. Do not mix units.

Metric	Definition	Required segmentation	Decision use
Outcome attainment	Eligible cases meeting the predeclared user/business outcome ÷ eligible cases	Use case, risk, cohort, time	Expand only when lower confidence bound clears target
Accepted-change rate	AI-assisted proposed changes accepted after review ÷ reviewed proposals	Change type and risk; never individual ranking	Detect workflow fit and review waste
Escaped-defect rate	Qualifying post-release defects ÷ releases or changed units	Severity, AI-assisted/non-assisted matched cohort	Compare quality with baseline
Evaluation coverage	Production decision paths represented by current qualified cases ÷ inventoried paths	Risk tier and release	Fund missing coverage; not a quality score
Severe-incident rate	Severe incidents ÷ exposed requests/users/decisions	Use case, provider/model release	Stop expansion or trigger retirement review
Human override rate	Human reversals of AI proposal ÷ reviewed AI proposals	Reason code and consequence	Detect calibration or workflow drift
Unit outcome cost	Total lifecycle cost ÷ successful outcomes	Model, human review, platform, evaluation, incident cost	Route/fund based on full cost, not token price
Exception exposure	Requests/users/side effects under active exception × days	Control and risk	Escalate aging or high-exposure exceptions
Time to safe recovery	Incident declaration to validated containment/restoration	Severity and failure type	Test operational readiness
Competence coverage	Qualified role assignments ÷ required assignments	Role and risk, not employee productivity	Fund training/hiring and constrain unsupported systems

Report numerator, denominator, exclusions, missingness, collection version, uncertainty, and owner. Small or sensitive cohorts are suppressed according to privacy policy.

Causal evaluation

• Establish at least four weeks of baseline where seasonality permits.
• Prefer randomized rollout by stable team/work unit when ethical and operationally feasible.
• Otherwise use matched workflows, interrupted time series, or difference-in-differences with declared assumptions.
• Track concurrent staffing, process, model, and workload changes; do not attribute the entire delta to AI.
• Pre-register primary outcome, guardrails, minimum detectable effect, horizon, exclusions, and stopping rule.
• Treat self-reported productivity as diagnostic context, not sole investment evidence.

Assurance plan

Independent assurance uses risk-weighted sampling:

Tier	Pre-launch	Operating sample	Triggered review
Low	Confirm inventory, owner, approved tooling, baseline tests	Annual sample or 5% of active uses, whichever is greater	Material incident or repeated exception
Medium	Verify evaluation, security, data, human workflow, rollback and provider evidence	Quarterly evidence sample plus one control replay	Provider/model change, severe complaint, drift
High	Independent end-to-end evidence review, witnessed failure/rollback exercise, affected-person process	Continuous key-risk indicators and quarterly control replay	Any severe outcome, oversight failure, legal/control change

Sampling percentages are starting policy values, not statistical guarantees. Assurance records the population, selection method, independence, exceptions, test steps, result, confidence limitations, and finding severity.

Finding and closure workflow

1. Assurance issues a finding with exact evidence, affected population/release, severity, control expectation, owner, and due date.
2. The use-case owner accepts remediation ownership; disagreement is recorded and escalated, not silently reworded.
3. Product/platform teams implement corrective action and attach new evidence.
4. Assurance independently re-performs the failed test. Ticket closure or management assertion is insufficient.
5. Recurring findings trigger root-cause review, control redesign, and portfolio-level funding.

Severity clocks are policy-defined. An overdue critical finding restricts or suspends the capability; it is not converted into an indefinite exception.

Portfolio decision rules

• Expand: primary outcome lower confidence bound exceeds target; all safety/security guardrails pass; controls and human capacity scale.
• Continue bounded: outcome uncertain but no risk threshold breached; collect the predeclared additional sample.
• Remediate: outcome valuable but control failure is correctable within approved time and exposure.
• Hold: severe incident, failed high-risk control, unqualified provider change, or expired exception.
• Retire: repeated failure, negative full-lifecycle value, unavailable competence/oversight, or no credible path within risk appetite.

Evidence contract

The decision record is the adoption and assurance review pack. It records outcome baseline; quality; incidents; override; cost; control coverage; workforce impact; remediation; retirement. The business use-case owner owns completeness; the evidence is invalid when activity measures are used as outcome or individual-performance proxies. Organization evidence records mandate, authority, competence, funding, conflicts, decisions, exceptions, metrics, and review cadence.

Failure response and recovery

Trigger: benefit is unproven or residual risk breaches appetite.

Immediate response: stop expansion, fund remediation, or retire the use case through portfolio review. Preserve the adoption and assurance review pack, affected trace IDs, timestamps, and decision logs before mutation. Open an incident when users, data, money, authorization, or a release decision may have been affected; closure requires a regression case and verified control change specific to ai adoption and assurance.

Decision authority

The business use-case owner accepts the operational decision. The independent assurance lead provides independent challenge for high-risk scope, failed gates, or exceptions. Committees may decide only within delegated authority; executives retain risk appetite and funding accountability while independent assurance retains challenge.

Tradeoffs

Choice	Benefit	Cost
Outcome metrics	Meaningful accountability	Harder attribution

Anti-patterns

• Counting prompts or generated lines.
• Ranking individuals by AI telemetry.

Enterprise considerations

• Consult workforce and privacy stakeholders.
• Use aggregated, purpose-limited telemetry.

Framework relationship

The AI Adoption and Assurance document is an operating aid; effectiveness requires observed decisions, funded controls, and independent evidence rather than the existence of this process.

Source	Relationship for AI Adoption and Assurance	Boundary
NIST AI RMF	GOVERN 4 and 6	Use NIST governance outcomes to test decision rights and accountability in practice.
ISO/IEC 42001	42001 clauses 9.1–9.3	A documented process supports—but does not itself demonstrate—effective management-system operation.
Domain threat/control source	Security findings are outcome guardrails	Test only the threats applicable to the documented system and release

Checklist

• Each metric has unit, numerator, denominator, missingness, uncertainty, owner, and decision rule.
• Outcome and guardrail metrics are predeclared before rollout.
• Causal claims identify design and assumptions.
• Telemetry is purpose-limited and cannot rank individuals.
• Assurance population, sample, independence, test steps, and confidence limits are recorded.
• Finding closure requires independent re-performance.
• Critical overdue findings and expired exceptions restrict exposure.
• Expand, bound, remediate, hold, and retire decisions are used in portfolio review.

References

• NIST, AI RMF 1.0, GOVERN 2–6 (accessed 2026-07-16).
• ISO, ISO/IEC 42001:2023, clauses 5–10 (accessed 2026-07-16). No certification or conformity claim is made.

Changelog

Version	Date	Change
1.1.0	2026-07-16	Added metric definitions, causal measurement, risk-weighted assurance sampling, finding closure, and portfolio expand/hold/retire rules.
1.0.0	2026-07-16	Initial complete profile.